
Kriya Therapeutics announces the establishment of its internal manufacturing facility for process development and scalable cGMP production of gene therapies for prevalent serious diseases
Date Published:
51,350 square foot operational manufacturing facility based in Research Triangle Park, North Carolina is designed to have its own fully …